SecSonar.com

Oramed Pharmaceuticals Inc. (ORMP)

Oramed Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Oramed Pharmaceuticals Inc. (ORMP) is a Biotechnology company based in US with a market capitalization of $162.9M. Free cash flow was negative at -$11.1M. This page tracks ORMP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13 employees · IPO May 1, 2007

Valuation

Valuation & price

$3.99 · as of May 23, 2026 · -20.2% vs 52w high

2.6

P/E ratio

Latest-FY diluted EPS

0.82

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.73$3.40$2.06Jul 25Dec 25Jul 26Jul 7, 25$2.16Jul 9, 25$2.17Jul 11, 25$2.13Jul 15, 25$2.09Jul 17, 25$2.12Jul 21, 25$2.12Jul 23, 25$2.30Jul 25, 25$2.16Jul 29, 25$2.20Jul 31, 25$2.15Aug 4, 25$2.09Aug 6, 25$2.09Aug 11, 25$2.09Aug 13, 25$2.12Aug 15, 25$2.08Aug 19, 25$2.06Aug 21, 25$2.06Aug 25, 25$2.17Aug 27, 25$2.21Aug 29, 25$2.20Sep 3, 25$2.20Sep 5, 25$2.23Sep 9, 25$2.31Sep 11, 25$2.43Sep 16, 25$2.29Sep 18, 25$2.44Sep 22, 25$2.47Sep 24, 25$2.40Sep 26, 25$2.41Sep 30, 25$2.64Oct 2, 25$2.51Oct 6, 25$2.45Oct 8, 25$2.39Oct 10, 25$2.41Oct 14, 25$2.36Oct 16, 25$2.27Oct 21, 25$2.34Oct 23, 25$2.37Oct 27, 25$2.37Oct 29, 25$2.37Oct 31, 25$2.39Nov 4, 25$2.28Nov 6, 25$2.20Nov 10, 25$2.28Nov 12, 25$2.47Nov 14, 25$2.33Nov 18, 25$2.49Nov 20, 25$2.42Nov 25, 25$2.88Nov 28, 25$2.85Dec 2, 25$2.75Dec 4, 25$2.72Dec 8, 25$2.69Dec 10, 25$2.90Dec 12, 25$3.07Dec 16, 25$3.08Dec 18, 25$2.98Dec 22, 25$2.96Dec 24, 25$3.15Dec 29, 25$2.91Jan 2, 26$2.91Jan 6, 26$3.07Jan 8, 26$3.48Jan 12, 26$3.43Jan 14, 26$3.64Jan 16, 26$3.68Jan 21, 26$3.44Jan 23, 26$3.39Jan 27, 26$3.48Jan 29, 26$3.42Feb 2, 26$3.40Feb 4, 26$3.42Feb 9, 26$3.43Feb 11, 26$3.25Feb 13, 26$3.25Feb 18, 26$3.30Feb 20, 26$3.22Feb 24, 26$3.46Feb 26, 26$3.43Mar 2, 26$3.34Mar 4, 26$3.62Mar 6, 26$3.29Mar 10, 26$3.33Mar 12, 26$3.38Mar 17, 26$3.61Mar 19, 26$3.61Mar 23, 26$3.55Mar 25, 26$3.50Mar 27, 26$3.31Mar 31, 26$3.40Apr 2, 26$3.42Apr 7, 26$3.52Apr 9, 26$3.52Apr 13, 26$3.79Apr 15, 26$3.82Apr 17, 26$3.88Apr 22, 26$3.90Apr 24, 26$3.85Apr 28, 26$4.03Apr 30, 26$3.88May 4, 26$3.93May 6, 26$3.92May 8, 26$4.09May 12, 26$4.45May 14, 26$4.73May 18, 26$4.29May 20, 26$4.28May 22, 26$3.99May 28, 26$3.96Jun 1, 26$3.89Jun 3, 26$3.65Jun 5, 26$3.71Jun 9, 26$3.65Jun 11, 26$3.80Jun 15, 26$3.84Jun 17, 26$3.79Jun 22, 26$4.01Jun 24, 26$4.30Jun 26, 26$4.67Jul 2, 26$4.54
$2.0652-week range$5.00
Loading valuation history…

Fundamentals

Key fundamentals

$162.9M

Market cap

—

Revenue growth (YoY)

0.7%

Gross margin

-$11.1M

Free cash flow (USD)

-$125.1M

Net debt

Net cash position

1.4%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$641.0KFY 2017$2.5MFY 2018$2.4MFY 2019$2.7MFY 2020$2.7MFY 2021$2.7MFY 2022$2.7MFY 2023$1.3MFY 2024$0.00FY 2025$2.0M
$641K$2M

Free cash flow by year

2016 → 2025

FY 2016$4.6MFY 2017$-5.8MFY 2018$-14.7MFY 2019$-13.0MFY 2020$-12.5MFY 2021$-21.6MFY 2022$-29.2MFY 2023$-10.5MFY 2024$-8.4MFY 2025$-11.1M
$4.6M-$11.1M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 20250.7%
100.0%0.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 19, 2026 (EPS $-0.16)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBylaws AmendedJun 30, 2026Filing
  • Quarterly report10-Q FiledMay 19, 2026Filing
  • 8-K eventAcquisition CompletedMar 31, 2026Filing

Questions

Frequently asked questions

What is Oramed Pharmaceuticals Inc.'s market cap?

Oramed Pharmaceuticals Inc. (ORMP) has a market capitalization of $162.9M.

What is ORMP's P/E ratio?

ORMP trades at a price-to-earnings ratio of 2.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ORMP's price-to-book (P/B) ratio?

ORMP trades at 0.82 times book value per share.

When did Oramed Pharmaceuticals Inc. last report earnings?

ORMP last reported earnings on May 19, 2026; the next date is not yet scheduled.

Are insiders buying ORMP stock?

SEC Form 4 filings show no open-market insider buys at Oramed Pharmaceuticals Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

SPRO

Spero Therapeutics, Inc.

$163.3M

VXRT

Vaxart, Inc.

$159.3M

UNCY

Unicycive Therapeutics, Inc.

$158.6M

MDWD

MediWound Ltd.

$157.8M

PRQR

ProQR Therapeutics N.V.

$168.6M

PLX

Protalix BioTherapeutics, Inc.

$170.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.